On Thursday and Friday, May 25-26, 2017, the Secretary’s Advisory Committee on Human Research Protections (SACHRP) met to discuss topics related to human research protections. The Committee reviewed recommendations pertaining to the new “Common Rule” (the Federal Policy for the Protection of Human Subjects) and recent FDA Draft Guidance regarding the use of real-world evidence to support regulatory decision-making for medical devices.
Back to All Events
Earlier Event: May 25Oncologic Drugs Advisory Committee
Later Event: June 20Endocrinologic and Metabolic Drugs Advisory Committee